Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Retatrutide's Phase 2a in MASH/MASLD (Sanyal et al., Nat Med 2024) reported approximately 86% relative reduction in liver fat content at 12 mg/week the strongest hepatic-fat data among the incretin class
Your initial series of treatments is designed to kickstart the regenerative process and awaken those sleepy hair follicles
Emerging Data on Nerve and Stem Cell Research Some studies imply that GHK-Cu may encourage nerve growth processes through interactions with growth factor expression
Fighting off yet another seasonal cold
US$ 29.34
US$ 23.40
US$ 28.94
US$ 25.93
US$ 25.60
